Aarhus University Seal / Aarhus Universitets segl

Aarhus Immunotherapy Symposia

Save the date:
November 25th 2021

  • 7th Aarhus Immunotherapy Symposium (AIS7)

Confirmed speakers

  • Stefan Vieths, Paul-Ehrlich-Institut, Langen, DE
  • José Carballido, Novartis, Basel, CH
  • Bjarke Hviid-Vyff, Aarhus University, Aarhus, DK
  • Duncan Howie, Enara Bio, Oxford, UK
  • Peter Holst, InProTher, Copenhagen, DK
  • Antoon van Oosterhout , Imcyse, Liege, BE
  • Marina Romero-Ramos, Aarhus University, DK

Previous symposia


6th Aarhus Immunotherapy Symposium (AIS6)

AIS6: New insights and therapies for immunological diseases

Thursday November 26th 2020, 3:00-6:30 PM CET 

Webinar 

3:00-4:00 pm CET 

Solange Peters, Lausanne University, Lausanne, CH: 

“Promises and limitations of immunotherapy for lung cancer” 

Malte Peters, Morphosys AG, Munich, DE: 

“Modern drug development using real world data approaches” 

-BREAK- 

4:15-5:45 pm CET 

Mario Ehlers, Boehringer Ingelheim, Ridgefield, US: 

“T cell exhaustion as a therapeutic strategy in autoimmunity” 

Stinne Greisen, Aarhus University, Aarhus, DK: ”Co-inhibitory receptors in arthritic conditions - their relation to disease activity and tissue preservation” 

Michael Ehrenstein, University College London, London, UK: ”Anti-TNF was the first regulatory T cell targeted therapy for rheumatoid arthritis” 

-BREAK- 

6:00-7:00 pm CET 

Adam Sander, AdaptVac, Copenhagen, DK: “Development of a COVID-19 vaccine based on virus-like particles displaying the SARS-CoV-2 receptor-binding domain” 

Stephen Durham, Imperial College, London, UK: “New indications for allergen immunotherapy” 

5th Aarhus Immunotherapy Symposium (AIS5)

AIS5: New insights and unexplored opportunities of Immunotherapy

Thursday November 28th, 2019 13:00-20:00 

Lake Side Lecture Theatres, Aarhus University, Aarhus, Denmark 

All talks 20 min + 10 min discussion 

13:00 - 14:00 registration & networking 

Session 1 

Chairs: Thomas Vorup-Jensen & Poul Sørensen 

Simon Davis, University of Oxford, UK (Keynote) 

14:00 - 14:40 Leveraging immune receptor signalling - new routes to therapeutic intervention 

Søren Paludan, Aarhus University, DK 

14:40 - 15:10 Modulation of lupus disease by targeting the STING pathway 

Philippe Moingeon, Servier, Suresnes, FR 

15:10 - 15:40 Molecular stratification of patients with autoimmune diseases: applications to new treatment development 

15:45 - 16:45 Coffee 

Session 2 

Chairs: Hans Jürgen Hoffmann & Philippe Moingeon 

Eric Vivier, Innate Pharma, Marseille, FR 

16:45 – 17:15 Targeting innate immunity in cancer 

Allan Jensen, Lundbeck, Valby, DK 

17:15 - 17:45 Active immunization for treatment or prevention of neurodegenerative diseases 

Georg du Toit, Kings College, London, UK 

17:45-18:15 Recent advances in the prevention of food allergy 

Networking and cocktail dinatoire 18:30 – 20:00 

Sign-up participants and sponsors: events.au.dk/AIS5 

4th Aarhus Immunotherapy Symposium (AIS4)

AIS4: Translational immunotherapy – crossing boundaries

Aarhus University: Thursday November 29th, 2018 13:00-22:00 

All talks 20 min + 10 min discussion

13:30 - 14:00 registration & networking

Welcome:  Dean, Faculty of Health, Aarhus University 

Chairs: Thomas Vorup-Jensen & Georg Holländer

Bernard Malissen, CIML, Marseille, FR (Keynote)

14:00 - 14:40 In the LEGO box of the TCR system ... from the list of parts to the assembly instructions!

Rikard Holmdahl, Karolinska Institutet, Stockholm, SE

14:40-15:10 How autoreactive lymphocytes learn about tissue specific antigens in cartilage

Søren Degn, Aarhus University, DK

15:10 - 15:40 Beyond antibodies – pleiotropic functions of B cells in autoimmune disease

Birgitte Ursø, LEO Pharma, Ballerup, DK

15:40 - 16:10 Translational drug discovery in biologics from early discovery to clinical testing

16:10 - 16:30 Pause 20 min, coffee

Chairs: Hans-Jürgen Hoffmann & Poul Sørensen

Georg Holländer, Univ. of Oxford, UK

16:30 – 17:00 Deconstructing the thymus: Molecular insight into thymus development and function

Eva Pålsson-McDermott, Trinity College, Dublin, IRL

17:00 - 17:30 The role of metabolic reprogramming in macrophage effector function

Peter S. Andersen, ALK, Hørsholm, DK

17:30-18:00 Antibody repertoire development during sublingual allergy immunotherapy 

Mo Shamji, Imperial College, London, UK

18:00-18:30 Peptide allergen immunotherapy: Ready for prime time

 

Networking and cocktail dinatoire 18:30 – 20:00

3rd Aarhus Immunotherapy Symposium (AIS3)

AIS3: Translational cancer immunotherapy – new biomarkers, targets and combinations

Aarhus University: Thursday November 30st, 2017 13:00-18:00

 

All talks 20 min + 10 min discussion

13:30 - 14:00 registration & networking

 

Welcome:  Ole Steen Nielsen, Vice-Dean, Faculty of Health, Aarhus University

Chairs: Thomas Vorup-Jensen & Poul Sørensen

John Haurum, F-star, Cambridge, UK (Keynote)

14:00 - 14:40 Immuno-oncology: Revolutionizing cancer care

José Moreira, Copenhagen University, Denmark

14:40-15:10 Biomarkers for patient risk stratification: a rational approach to cancer prevention

Martin R. Jakobsen, Aarhus University, Denmark

15:10 - 15:40 Triggering the innate immune system: a novel approach to tumour remission

Per thor Straten, University Hospital Herlev, Denmark

15:40 - 16:10 Therapy of solid cancers using T cells and running shoes 

16:10 - 16:30 Pause 20 min, coffee 

Ivan Horak, Symphogen, Lyngby, Denmark

16:30 – 17:00 Precision medicine in the era of targeted therapy; from clinic back to bench

Ida Hiemstra, Genmab, Utrecht, Holland

17:00 - 17:30 Translating basic science to antibody therapeutics

Bent Jakobsen, Immunocore, Oxford, UK

17:30-18:00 Fine-tuned T cell receptors for cancer immunotherapy

 

Networking and dinner   18:00 – 22:00

1st Aarhus Immunotherapy Symposium (AIS1)

AIS1: A Christmas Symposium: The Gifts of Allergen Immunotherapy

Thursday 3 December 2015 14:00 - 19:00 

Merete Barker Aud., The Lakeside Lecture Theatres, Bartholins Allé 3, 8000 Aarhus C  

14:00 - 14:30 Registration & networking 

All talks 20 min + 5 min discussion 

Session 1: AIT State-of-the-Art 

Chairs: Hans Jürgen Hoffmann, Aarhus University & Hospital; Poul Sørensen, Stallergenes Greer & Aarhus University; Steffen Thiel, Aarhus University 

14:30 - 14:55 Allergen Immunotherapy Efficacy, safety and long term benefits. SCIT or SLIT? 

Prof. Stephen R. Durham, Imperial College London, UK 

14:55 - 15:20 Tolerance induction and prevention in allergy - a public health issue 

Prof. Erkka Valovirta, University of Turku, Turku, Finland 

15:20 - 15:45 Clinical Outcome Measures in AIT 

Prof. Oliver Pfaar, Heidelberg University & Center for Rhinology and Allergology, 

Wiesbaden, DE: 

15:45 - 16:10 Biomarkers of SLIT efficacy: a "panorOmic" view 

Dr. Philippe Moingeon, Stallergenes Greer, Paris, France 

16:10 - 16:35 Basophil Sensitivity and ISAC as Biomarkers for SCIT 

Dr. Johannes Schmid, Aarhus University, Denmark 

16:35 - 17:00 Coffee break and networking 

Session 2: Emerging new AIT approaches 

Chairs: Hans-Jørgen Malling, Gentofte Hospital, Hellerup; Edzard Spillner, Immunological Engineering, Aarhus University 

17:05 - 17:30 Targeting T cells with peptide immunotherapy 

Prof. Mark Larché, McMaster University, Hamilton, Ontario, Canada 

17:30 - 18:05 The good “COP”: AIT with <10% of the doses needed with extracts 

Dr. Kim Simonsen, Chief Development Officer, Anergis SA, Switzerland 

18:05 - 18:30 Introducing ILIT in Sweden 

Prof. Lars Olaf Cardell, Lund University & Karolinska Institute, Sweden 

18:30 - 19:00 A double-blind, placebo controlled trial to compare three and four injections in ILIT 

Dr. Søren Helbo, Aarhus University, Aarhus, Denmark 

19:15 Dinner and networking at ”Kemisk Kantine”, Langelandsgade 38, Bldg. 1510, 8000 Aarhus C 

Date

November 25 2021


Venue

TBA


Symposium invitation

Symposium invitation